Factors Associated with Discharge Outcomes in Elderly Patients with Glioblastoma

When a person is diagnosed with a glioblastoma, a highly aggressive form of brain cancer, the medical focus often shifts quickly to survival time. Yet for the elderly, who make up a significant portion of these cases, the immediate goal is often more practical: can they return to their own home after treatment, or will they need to move to a care facility? This question sits at the intersection of neurosurgery and rehabilitation. The challenge is that the disease, the surgery to remove it, and the subsequent radiation and chemotherapy can leave patients with profound physical and mental changes. Unlike a stroke, which often strikes suddenly, a brain tumor grows slowly, and its treatment can be a long, draining process that erodes a person's ability to perform daily tasks like walking, eating, or managing their own care. Understanding what allows an older patient to go home rather than to a nursing facility is not just about medical success; it is about preserving dignity and the familiar rhythms of a life lived in one's own space.

Researchers at Asahikawa Medical University Hospital in Japan set out to understand exactly what tipped the scales for elderly patients with this specific type of brain tumor. They looked back at the medical records of twenty-six patients, all aged sixty-five or older, who had been newly diagnosed with glioblastoma between 2021 and 2024. Every single one of these individuals underwent surgery to remove the tumor, followed by standard chemotherapy and radiation, and then a period of rehabilitation therapy in the hospital. The team split these patients into two groups based on where they ended up after their hospital stay: thirteen went home, and thirteen were transferred to other medical or care facilities. By comparing the two groups, the researchers hoped to find the specific factors that made the difference.

The study began by checking the basics. The researchers looked at the patients' ages, their body mass, their medical histories, and whether they lived with a spouse or children before they got sick. They found that these factors did not distinguish the two groups. Whether a patient lived alone or with family, or whether they had high blood pressure or diabetes, did not predict their discharge destination. However, the location of the tumor within the brain did matter. Patients who ended up in a care facility were significantly more likely to have tumors affecting the parietal lobe, a region of the brain involved in processing sensory information and spatial awareness. This suggests that damage to this specific area creates hurdles that are harder to overcome during recovery.

The most striking difference emerged when the researchers examined the patients' ability to move. The group that went home spent an average of forty-four and a half days in rehabilitation, while the group that transferred to a facility stayed for an average of fifty-seven and a half days. More importantly, the ability to walk at the time of discharge was the clearest divider. Patients who went home were able to walk with a higher level of independence than those who did not. In contrast, the group that went to a facility had started their hospital stay with better cognitive scores, meaning they were more aware and mentally sharp when they first arrived. The group that went home started with lower cognitive scores, suggesting their families and living situations had already adapted to their needs before they ever entered the hospital.

This finding challenges a common assumption that having a family member at home guarantees a return to that home. While having a spouse or children is often seen as a safety net, this study showed that their mere presence was not enough to ensure a discharge to home. The researchers noted that in this elderly population, the caregivers themselves were often older and potentially unable to handle the intense physical and emotional demands of caring for someone with a brain tumor. The data suggested that the physical capacity to walk was a more reliable predictor of going home than the presence of a caregiver. If a patient could not walk well enough to navigate their own home, the support of a family member could not compensate for that physical limitation.

The study also highlighted the complexity of the brain's role in recovery. The fact that patients with parietal lobe involvement were more likely to transfer to facilities points to the importance of higher-order brain functions. These functions include the ability to understand where one's body is in space and to navigate the environment safely. When these abilities are compromised, the risk of falling or getting lost increases, making independent living difficult regardless of how much help is available. The researchers concluded that while a supportive home environment is valuable, it cannot replace the fundamental need for physical mobility.

Ultimately, this research offers a clear, if sobering, guide for families and doctors. It suggests that for elderly patients with glioblastoma, the path to returning home is paved with walking ability. Rehabilitation efforts that focus intensely on maintaining or restoring the ability to walk may be the most critical factor in determining where a patient spends their remaining time. The study does not claim to have solved the problem of brain cancer, nor does it promise that every patient who can walk will go home. Instead, it provides a realistic picture of the hurdles these patients face, showing that the physical act of moving through the world is often the deciding factor between a return to the familiar and a move to a new, institutional setting.